{"abstract":"The Food and Drug Administration (FDA) is announcing a public conference entitled \"Serious Drug-Induced Liver Injury (DILI): The Importance of Getting It Right: How to Measure and Interpret DILI Information and Make Correct Diagnoses.\" This conference will be cosponsored with the Critical Path Institute (C-Path) and the Pharmaceutical Research and Manufacturers of America. The purpose of the public conference is to discuss, debate, and share views among stakeholders in the pharmaceutical industry, academia, health care providers, patient groups, and regulatory bodies on how best to detect and assess the severity, extent, and likelihood of drug causation of liver injury and dysfunction in people using drugs for any medical purpose.","action":"Notice of public conference; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/12/19/2014-29720.html","cfr_references":[],"citation":"79 FR 75822","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The public conference will be held on March 18, 2015, from 8 a.m. to 6 p.m. and on March 19, 2015, from 8 a.m. to 4 p.m.","disposition_notes":null,"docket_ids":["Docket No. FDA-2008-D-0128"],"dockets":[],"document_number":"2014-29720","effective_on":null,"end_page":75822,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/12/19/2014-29720.xml","html_url":"https://www.federalregister.gov/documents/2014/12/19/2014-29720/serious-drug-induced-liver-injury-the-importance-of-getting-it-right-how-to-measure-and-interpret","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-29720?publication_date=2014-12-19","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-12-19/2014-29720/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":162,"last_updated":"2026-04-10 08:15:11 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-12-19/pdf/2014-29720.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-29720.pdf?1418910579","publication_date":"2014-12-19","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/12/19/2014-29720.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2008-D-0128","supporting_documents_count":0,"docket_id":"FDA-2008-D-0128","regulation_id_number":null,"title":"Drug-Induced Liver Injury: Premarketing Clinical Evaluation","checked_regulationsdotgov_at":"2015-01-12T19:22:16Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":75822,"subtype":null,"title":"Serious Drug-Induced Liver Injury: The Importance of Getting It Right: How To Measure and Interpret Drug-Induced Liver Injury Information and Make Correct Diagnoses; Public Conference; Request for Comments","toc_doc":"Serious Drug-Induced Liver Injury  The Importance of Getting It Right  How to Measure and Interpret Drug-Induced Liver Injury Information and Make Correct Diagnoses; Public Conferences","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":79}